RED DEER, AB, Oct. 14, 2020 /CNW/ – CanadaBis Capital Inc. (“CanadaBis” or “the Company”) is a vertically integrated Canadian cannabis company focused on capitalizing future growth and diversification opportunities. The Company is pleased to announce several updates from its subsidiary Stigma Grow (“1998643 AB LTD.”) including new, in-demand full-spectrum product lines and an advantageous new partnership that ensures product availability across Canada.
As first-to-market Canadian producers of full-spectrum, live-resin concentrates, Stigma Grow’s state-of-the-art butane hydrocarbon extraction system (BHO) processes some of the purist, most potent products available on today’s legal market.
An overwhelmingly positive response to their initial product offerings led the Company to spend their summer months investing in the increase of their facility’s processing capacity by 300%; ensuring they could manage the increase in demand for Stigma Grow products, as well as an influx of white-label requests from some of biggest names in legal cannabis.
In addition to powerful live-resin caviars and badders/budders, Stigma Grow now offers full-spectrum lineup of bud-run, strain-specific shatters, live-resin vape cartridges, crumbles, diamonds and live-resin sauce; the most comprehensive and impressive BHO hydrocarbon concentrates lineup from a Canadian company to-date.
Simultaneously, Stigma’s R&D department remains committed to exploring a plethora of exciting new product opportunities for both a growing list of third-party partners, and future consumers interested in new and improved Cannabis 3.0 products.
Equipped with product purity and pricing that few providers can match, Stigma Grow recently signed a new national distribution deal with Namaste Technologies to sell their products across Canada through CannMart, a move that will bring hope to a lot of retailers unsatisfied with the status quo.
“Our ongoing mission as a Company is to align with cannabis growers, distributors and retailers to ensure the highest-quality cannabis concentrates are available wherever savvy consumers are looking for something exceptional,” says Travis McIntyre, CEO of Stigma Grow. “This agreement with CannMart is in perfect alignment with our promise to Canadians and builds on the success and momentum that we have already seen in the provinces where our product is sold. We’re excited to bring our unique live-resin, full-spectrum BHO products to as many stores across Canada as we can”.
In addition to their blossoming concentrates pillar, the Company’s cultivation and retail pillars are also celebrating milestones.
Stigma’s cultivation pillar recently expanded its grow space by more than 200% and, in addition to high-potency (28% THC) pre-rolls, it continues to provide Stigma’s concentrates pillar with consistent, high-quality flower capable of supplying input to their highest-quality products.
From a retail standpoint, INDICAtive Collection, located in Red Deer’s Gasoline Alley, celebrated its one-year anniversary on October 4th, 2020. INDICAtive Collection experienced consistent growth over its first 12 months of business, while two competing locations within the same Gasoline Alley closed their doors in their first year of business.
About Namaste Technologies Inc.
With headquarters in Toronto, ON, Namaste Technologies is a leading online platform for cannabis products, accessories, and responsible education. The Company’s ‘everything cannabis store’, CannMart.com, provides cannabis customers with a diverse selection of hand-picked products from a multitude of federally licensed cultivators, all on one convenient site.
About Stigma Grow
We are a cutting-edge cannabis cultivation and extraction company positioned advantageously to meet the unmet market demands and stigmas within the legal cannabis industry head on, with products designed to disturb the status quo and dramatically shift the conversation surrounding Canada’s legal cannabis industry.
About CanadaBis Capital Inc.
CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the fast-emerging global cannabis market. By targeting organic growth opportunities alongside the right-fit partners, we remain focused on finding and capitalizing on chances to grow, diversify and continue to lead our industry.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to our business and operations including development and expansion plans; intention to develop property in British Columbia; increasing our product lines to include CBD distillates; and our general business plans. Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: compliance with extensive government regulation, the general business, economic, competitive, political and social uncertainties; successful negotiation of necessary agreements to get our product to market; requirement for further capital, delay or failure to receive board, shareholder or regulatory approvals; the results of operations and such other matters as set out in the Filing Statement available on SEDAR at www.sedar.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward-looking statements. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although we believe that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have a material adverse effect on our future results, performance or achievements.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. CanadaBis Capital does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE CanadaBis Capital Inc.
For further information: on CanadaBis Capital, 1998643 (Stigma Grow), or INDICAtive Collection please visit www.canadabis.com, www.stigmagrow.ca, www.indicativecollection.ca or contact:Investor Relations: Info@CanadaBis.com, 1-888-STIGMA1